Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial.
Shanbhag NM, Padmanabhan JL, Zhang Z, Harel BT, Jia H, Kangarloo T, Yin W, Dowling AV, Laurenza A, Khudyakov P, Galinsky K, Latzman RD, Simuni T, Weintraub D, Horak FB, Lustig C, Maruff P, Simen AA. Shanbhag NM, et al. Among authors: harel bt. JAMA Neurol. 2025 Jan 6. doi: 10.1001/jamaneurol.2024.4519. Online ahead of print. JAMA Neurol. 2025. PMID: 39761063
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials.
Zaragoza Domingo S, Alonso J, Ferrer M, Acosta MT, Alphs L, Annas P, Balabanov P, Berger AK, Bishop KI, Butlen-Ducuing F, Dorffner G, Edgar C, de Gracia Blanco M, Harel B, Harrison J, Horan WP, Jaeger J, Kottner J, Pinkham A, Tinoco D, Vance M, Yavorsky C. Zaragoza Domingo S, et al. Among authors: harel b. Eur Neuropsychopharmacol. 2024 Jun;83:32-42. doi: 10.1016/j.euroneuro.2024.02.009. Epub 2024 Apr 4. Eur Neuropsychopharmacol. 2024. PMID: 38579661 Free article. Review.
Investigation of genetic determinants of cognitive change in later life.
Mahedy L, Anderson EL, Tilling K, Thornton ZA, Elmore AR, Szalma S, Simen A, Culp M, Zicha S, Harel BT, Davey Smith G, Smith EN, Paternoster L. Mahedy L, et al. Among authors: harel bt. Transl Psychiatry. 2024 Jan 18;14(1):31. doi: 10.1038/s41398-023-02726-6. Transl Psychiatry. 2024. PMID: 38238328 Free PMC article.
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity.
Balice-Gordon R, Honey GD, Chatham C, Arce E, Duvvuri S, Naylor MG, Liu W, Xie Z, DeMartinis N, Harel BT, Braley GH, Kozak R, Park L, Gray DL. Balice-Gordon R, et al. Among authors: harel bt. Int J Neuropsychopharmacol. 2020 May 27;23(5):287-299. doi: 10.1093/ijnp/pyaa007. Int J Neuropsychopharmacol. 2020. PMID: 32055822 Free PMC article. Clinical Trial.
Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences.
Soutschek A, Gvozdanovic G, Kozak R, Duvvuri S, de Martinis N, Harel B, Gray DL, Fehr E, Jetter A, Tobler PN. Soutschek A, et al. Among authors: harel b. Biol Psychiatry. 2020 Apr 1;87(7):678-685. doi: 10.1016/j.biopsych.2019.09.002. Epub 2019 Sep 12. Biol Psychiatry. 2020. PMID: 31668477 Free article. Clinical Trial.
37 results